Minerva Surgical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UTRS research report →
Companyminervasurgical.com
Minerva Surgical, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
- CEO
- Darin Hammers
- IPO
- 2021
- Employees
- 174
- HQ
- Santa Clara, CA, US
Price Chart
Valuation
- Market Cap
- $888
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54.17%
- Op Margin
- -61.44%
- Net Margin
- -67.83%
- ROE
- -111.32%
- ROIC
- -54.33%
Growth & Income
- Revenue
- $50.29M · -3.47%
- Net Income
- $-34,112,000 · -58.93%
- EPS
- $-23.68 · -58.08%
- Op Income
- $-30,899,000
- FCF YoY
- -55.21%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.60
- Avg Volume
- 33
Get TickerSpark's AI analysis on UTRS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 1, 23 | Cohen Daniel | other | 0 |
| Feb 9, 23 | NEW ENTERPRISE ASSOCIATES 13 LP | buy | 24,437,927 |
| Feb 9, 23 | Accelmed Partners II L.P. | other | 0 |
| Feb 9, 23 | Geiger Uri | other | 0 |
| Jan 2, 23 | Usen Todd | other | 0 |
| May 2, 22 | Skalnyi Evgueni V. | other | 49,755 |
| May 2, 22 | Filloux Dominique J. | other | 60,198 |
| May 2, 22 | Jung Joel R | other | 60,198 |
| May 2, 22 | Clapper David M | other | 229,732 |
| Jul 19, 22 | Sung Derrick | other | 86,956 |
Our UTRS Coverage
We haven't published any research on UTRS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate UTRS Report →